Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Bupa UK launches GP subscription service for £200 per year

The UK branch of British multinational healthcare company Bupa is launching a new direct-to-consumer subscription service for primary care, giving customers access to same-day appointments with a private GP, starting at just over £200 per year.
September 6, 2024

Remote patient monitoring can cut chronic disease care costs by 40% — an interview with Lasse Rousi, Medixine 

Over the coming years and decades an increasing amount of care will be delivered to patients in their homes. New devices and wearables that can collect health data from people whilst they’re at home and healthcare’s digitalisation trend are opening up new possibilities, both for prevention and for providing better and more efficient care to those with chronic conditions. 
September 5, 2024

FREE BLOG Paris in the springtime

Watching Paris host first the Olympic Games and now the Paralympic Games has been a pleasure that I’m sure many of you will have enjoyed this summer. The Games, which have been organised to be the most sustainable ever, have proven the ultimate showcase for a city which will always be synonymous with enlightenment and of course romance.
September 4, 2024

HBI News Round Up, Friday 30th August 2024

In this HBI News Round Up we cover the investment summary of pan-European firm Affidea's Romanian branch the first half of 2024, global leader in RNA-based genomic diagnostics BioNexus Gene Lab Corp’s investment into a pioneering Malaysian healthcare technology firm, Ascension Innovation Sdn Bhd, and Portuguese hospital group CUF's profits results for the first half of 2024.
August 30, 2024

Accenture to expand healthcare capabilities in Germany with acquisition of consus.health

Tech consultancy firm Accenture is going to expand its healthcare capabilities in Germany with the acquisition of leading German healthcare management consultancy, consus.health. The details of the acquisition, which is expected to complete subject to customary closing conditions, were not disclosed. Freiburg im Breisgau-based consus.health was founded in 2012 and has more than 600 healthcare […]
August 29, 2024

Mubadala and CBC Group acquire Belgian biopharma UCB’s China operations

UCB, a Belgian biopharma company, plans to divest its business in China, to CBC Group, a Singapore-based investment firm, and Mubadala, a global investment company from Abu Dhabi, for $680 million.  The deal, pending regulatory approval, is expected to close in Q4 2024 and includes UCB’s neurology and allergy portfolios, as well as its manufacturing site in Zhuhai, China.
August 29, 2024

UK launches £400 million public-private partnership to address critical need in pharmaceutical testing

The UK’s Department of Health and Social Care (DHSC), NHS England, and the Association of the British Pharmaceutical Industry (ABPI) have launched a £400 million initiative to improve the country’s pharmaceutical testing capabilities. Termed the ‘Voluntary Scheme for Branded Medicine Pricing, Access and Growth’ (VPAG), this public-private investment will create up to 18 new clinical trial hubs across the UK, speeding up the development and availability of new medicines, as detailed in the August 28 press release.
August 29, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us